SEOM clinical guideline on hereditary colorectal cancer (2019)

被引：10

作者：

Guillen-Ponce, C. ^{[1
]}

Lastra, E. ^{[2
]}

Lorenzo-Lorenzo, I ^{[3
]}

Martin Gomez, T. ^{[4
]}

Morales Chamorro, R. ^{[5
]}

Sanchez-Heras, A. B. ^{[6
]}

Serrano, R. ^{[7
]}

Soriano Rodriguez, M. C. ^{[8
]}

Soto, J. L. ^{[9
]}

Robles, L. ^{[10
]}

机构：

[1] Hosp Univ Ramon y Cajal, Med Oncol Dept, IRYCIS, Carretera Colmenar Viejo,Km 9,100, Madrid 28034, Spain

[2] Hosp Univ Burgos, Med Oncol Dept, Burgos, Spain

[3] Complejo Hosp Univ Vigo CHUVI, Med Oncol Dept, Pontevedra, Spain

[4] Hosp Univ Salamanca, Med Oncol Dept, Salamanca, Spain

[5] Hosp Gen La Mancha Ctr, Med Oncol Dept, Ciudad Real, Spain

[6] Hosp Gen Univ Elche, Med Oncol Dept, Alicante, Spain

[7] Hosp Univ Reina Sofia, Med Oncol Dept, CIBERONC, IMIBIC, Cordoba, Spain

[8] Hosp Gen Virgen de la Luz, Med Oncol Dept, Cuenca, Spain

[9] Hosp Gen Univ Elche, Mol Genet Lab, Alicante, Spain

[10] Hosp Univ Doce Octubre, Med Oncol Dept, Madrid, Spain

来源：

CLINICAL & TRANSLATIONAL ONCOLOGY | 2020年 / 22卷 / 02期

关键词：

Lynch syndrome; Adenomatous polyposis; Hereditary colorectal cancer; Colon cancer; MISMATCH-REPAIR DEFICIENCY; SUSCEPTIBILITY GENE-MUTATIONS; LYNCH SYNDROME; ENDOMETRIAL CANCERS; COST-EFFECTIVENESS; GERMLINE; RISK; COLON; MANAGEMENT; GRADE;

D O I：

10.1007/s12094-019-02272-y

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

In the last 2 decades, clinical genetics on hereditary colorectal syndromes has shifted from just a molecular characterization of the different syndromes to the estimation of the individual risk of cancer and appropriate risk reduction strategies. In the last years, new specific therapies for some subgroups of patients have emerged as very effective alternatives. At the same time, germline multigene panel testing by next-generation sequencing (NGS) technology has become the new gold standard for molecular genetics.

引用

页码：201 / 212

页数：12

共 50 条

[1] SEOM clinical guideline on hereditary colorectal cancer (2019)
C. Guillén-Ponce
E. Lastra
I. Lorenzo-Lorenzo
T. Martín Gómez
R. Morales Chamorro
A. B. Sánchez-Heras
R. Serrano
M. C. Soriano Rodríguez
J. L. Soto
L. Robles
Clinical and Translational Oncology, 2020, 22 : 201 - 212
[2] Clinical guideline seom: hereditary colorectal cancer
Guillen-Ponce, C.
Serrano, R.
Sanchez-Heras, A. B.
Teule, A.
Chirivella, I.
Martin, T.
Martinez, E.
Morales, R.
Robles, L.
CLINICAL & TRANSLATIONAL ONCOLOGY, 2015, 17 (12) : 962 - 971
[3] Clinical guideline seom: hereditary colorectal cancer
C. Guillén-Ponce
R. Serrano
A. B. Sánchez-Heras
A. Teulé
I. Chirivella
T. Martín
E. Martínez
R. Morales
L. Robles
Clinical and Translational Oncology, 2015, 17 : 962 - 971
[4] SEOM clinical guideline thyroid cancer (2019)
Gallardo, E.
Medina, J.
Sanchez, J. C.
Viudez, A.
Grande, E.
Porras, I.
Ramon y Cajal, T.
Trigo, J.
Iglesias, L.
Capdevila, J.
CLINICAL & TRANSLATIONAL ONCOLOGY, 2020, 22 (02) : 223 - 235
[5] SEOM clinical guidelines for hereditary cancer
Grana, Begona
Lastra, Enrique
Llort, Gemma
Brunet, Joan
Isla, Dolores
CLINICAL & TRANSLATIONAL ONCOLOGY, 2011, 13 (08) : 580 - 586
[6] Advances in Hereditary Colorectal Cancer: Opportunities and Challenges for Clinical Translation
DeSouza, Bianca
Georgiou, Demetra
CURRENT GENETIC MEDICINE REPORTS, 2020, 8 (02) : 47 - 60
[7] SEOM clinical guidelines for hereditary cancer
Begoña Graña
Enrique Lastra
Gemma Llort
Joan Brunet
Dolores Isla
Clinical and Translational Oncology, 2011, 13 : 580 - 586
[8] Update on Hereditary Colorectal Cancer
Da Silva, Felipe Carneiro
Wernhoff, Patrik
Dominguez-Barrera, Constantino
Dominguez-Valentin, Mev
ANTICANCER RESEARCH, 2016, 36 (09) : 4399 - 4405
[9] Clinical Genetics of Hereditary Colorectal Cancer
Power, Derek G.
Gloglowski, Emily
Lipkin, Steven M.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2010, 24 (05) : 837 - +
[10] Hereditary colorectal cancer
Hindi Muniz, Nadia
Lamarca Lete, Angela
Feliu Batlle, Jaime
MEDICINA CLINICA, 2012, 138 (05): : 220 - 223

← 1 2 3 4 5 →